Volume 13, Number 6—June 2007
Research
Risk Factors for Imported Fatal Plasmodium falciparum Malaria, France, 1996–2003
Table 3
Clinical data | No. travelers (%) |
---|---|
Initial symptoms | |
Fever | 80 (83.3) |
Mental status changes | 45 (46.9) |
Jaundice | 24 (25) |
Diarrhea | 18 (18.7) |
Respiratory symptoms | 13 (13.5) |
Coma | 11 (11.5) |
Vomiting | 9 (9.4) |
Convulsions | 6 (6.2) |
Lethargy | 5 (5.2) |
Cough | 4 (4.2) |
Shock syndrome | 4 (4.2) |
Severity criteria* during clinical course | |
Renal failure | 70 (72.9) |
Shock syndrome | 60 (62.5) |
Cerebral malaria | 55 (57.3) |
Acute respiratory distress syndrome | 44 (45.8) |
Acidosis | 36 (37.5) |
Disseminated intravascular coagulation | 30 (31.2) |
Pulmonary edema | 12 (12.5) |
Scleral icterus | 11 (11.5) |
Convulsions | 9 (9.4) |
Other conditions | |
Nosocomial infection | 24 (25) |
Cardiac failure | 49 (51) |
Cerebral edema | 10 (10.4) |
*Severity criteria according to World Health Organization, 2000.
Page created: May 31, 2011
Page updated: May 31, 2011
Page reviewed: May 31, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.